Zhan J, Zhang P, Wen H, Wang Y, Yan X, Zhan L, et al. Global prevalence estimates of poststroke fatigue: a systematic review and meta-analysis. Int J Stroke. 2023;18(9):1040–50.

Article  PubMed  Google Scholar 

Hill G, Regan S, Francis R. Research priorities to improve stroke outcomes. Lancet Neurol. 2022;21(4):312–3.

Article  PubMed  PubMed Central  Google Scholar 

English C, Simpson DB, Billinger SA, Churilov L, Coupland KG, Drummond A et al. A roadmap for research in post-stroke fatigue: consensus-based core recommendations from the third stroke recovery and rehabilitation roundtable. Int J Stroke. 2023:17474930231189135.

Zhang S, Cheng S, Zhang Z, Wang C, Wang A, Zhu W. Related risk factors associated with post-stroke fatigue: a systematic review and meta-analysis. Neurol Sci. 2021;42(4):1463–71.

Article  PubMed  Google Scholar 

Bivard A, Lillicrap T, Krishnamurthy V, Holliday E, Attia J, Pagram H, et al. MIDAS (Modafinil in debilitating fatigue after stroke): a randomized, double-blind, placebo-controlled, cross-over trial. Stroke. 2017;48(5):1293–8.

Article  PubMed  PubMed Central  Google Scholar 

Klein J, Wood J, Jaycox JR, Dhodapkar RM, Lu P, Gehlhausen JR, et al. Distinguishing features of long COVID identified through immune profiling. Nature. 2023;623(7985):139–48.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Shikova E, Reshkova V, Kumanova А, Raleva S, Alexandrova D, Capo N, Cytomegalovirus, et al. Epstein-Barr virus, and human herpesvirus-6 infections in patients with myalgic еncephalomyelitis/chronic fatigue syndrome. J Med Virol. 2020;92(12):3682–8.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cohen JI. Epstein-Barr virus infection. N Engl J Med. 2000;343(7):481–92.

Article  PubMed  CAS  Google Scholar 

Kerr JR. Epstein-Barr virus (EBV) reactivation and therapeutic inhibitors. J Clin Pathol. 2019;72(10):651–8.

Article  PubMed  CAS  Google Scholar 

Ru Y, Zhang X, Song T, Ding Y, Zhu Z, Fan Y, et al. Epstein-Barr virus reactivation after allogeneic hematopoietic stem cell transplantation: multifactorial impact on transplant outcomes. Bone Marrow Transpl. 2020;55(9):1754–62.

Article  CAS  Google Scholar 

San-Juan R, Comoli P, Caillard S, Moulin B, Hirsch HH, Meylan P. Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients. Clin Microbiol Infect. 2014;20(Suppl 7):109–18.

Article  PubMed  Google Scholar 

Ferbas J, Rahman MA, Kingsley LA, Armstrong JA, Ho M, Zhou SY, et al. Frequent oropharyngeal shedding of Epstein-Barr virus in homosexual men during early HIV infection. Aids. 1992;6(11):1273–8.

Article  PubMed  CAS  Google Scholar 

Stevens SJ, Blank BS, Smits PH, Meenhorst PL, Middeldorp JM. High Epstein-Barr virus (EBV) DNA loads in HIV-infected patients: correlation with antiretroviral therapy and quantitative EBV serology. Aids. 2002;16(7):993–1001.

Article  PubMed  CAS  Google Scholar 

Glaser R, Pearson GR, Jones JF, Hillhouse J, Kennedy S, Mao HY, et al. Stress-related activation of Epstein-Barr virus. Brain Behav Immun. 1991;5(2):219–32.

Article  PubMed  CAS  Google Scholar 

Ruiz-Pablos M. CD4 + cytotoxic T cells involved in the development of EBV-associated diseases. Pathogens. 2022;11(8).

Fevang B, Wyller VBB, Mollnes TE, Pedersen M, Asprusten TT, Michelsen A, et al. Lasting immunological imprint of primary Epstein-Barr virus infection with associations to chronic low-grade inflammation and fatigue. Front Immunol. 2021;12:715102.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hoffmann S, Harms H, Ulm L, Nabavi DG, Mackert B-M, Schmehl I, et al. Stroke-induced immunodepression and dysphagia independently predict stroke-associated pneumonia – the PREDICT study. J Cereb Blood Flow Metab. 2016.

Prass K, Meisel C, Hoflich C, Braun J, Halle E, Wolf T et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med. 2003;198.

McCulloch L, Smith CJ, McColl BW. Adrenergic-mediated loss of splenic marginal zone B cells contributes to infection susceptibility after stroke. Nat Commun. 2017;8:15051.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Elkind MSV, Boehme AK, Smith CJ, Meisel A, Buckwalter MS. Infection as a stroke risk factor and determinant of outcome after stroke. Stroke. 2020;51(10):3156–68.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Tung YC, Tu HP, Wu MK, Kuo KL, Su YF, Lu YY, et al. Higher risk of herpes zoster in stroke patients. PLoS ONE. 2020;15(2):e0228409.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bertrand L, Méroth F, Tournebize M, Leda AR, Sun E, Toborek M. Targeting the HIV-infected brain to improve ischemic stroke outcome. Nat Commun. 2019;10(1):2009.

Article  PubMed  PubMed Central  Google Scholar 

Gumenyuk А, Motorna N, Rybalko S, Savosko S, Sokurenko L, Starosyla D, et al. Development of herpetic infection associated with stroke and its correction with acyclovir. Curr Issues Pharm Med Sci. 2017;30(1):20–3.

Article  Google Scholar 

Drag LL, Mlynash M, Nassar H, Osborn E, Kim DE, Angst MS, et al. A longitudinal study of the post-stroke immune response and cognitive functioning: the StrokeCog study protocol. BMC Neurol. 2020;20(1):313.

Article  PubMed  PubMed Central  Google Scholar 

Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E. Measuring fatigue and other anemia-related symptoms with the functional assessment of cancer therapy (FACT) measurement system. J Pain Symptom Manage. 1997;13(2):63–74.

Article  PubMed  CAS  Google Scholar 

Duncan PW, Bode RK, Min Lai S, Perera S. Rasch analysis of a new stroke-specific outcome scale: the stroke impact scale. Arch Phys Med Rehabil. 2003;84(7):950–63.

Article  PubMed  Google Scholar 

Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–9.

Article  PubMed  Google Scholar 

Butt Z, Lai JS, Rao D, Heinemann AW, Bill A, Cella D. Measurement of fatigue in cancer, stroke, and HIV using the functional assessment of chronic illness therapy - fatigue (FACIT-F) scale. J Psychosom Res. 2013;74(1):64–8.

Article  PubMed  Google Scholar 

Smith CJ, Emsley HCA, Gavin CM, Georgiou RF, Vail A, Barberan EM, et al. Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol. 2004;4(1):2.

Article  PubMed  PubMed Central  Google Scholar 

Brengel-Pesce K, Morand P, Schmuck A, Bourgeat MJ, Buisson M, Barguès G, et al. Routine use of real-time quantitative PCR for laboratory diagnosis of Epstein-Barr virus infections. J Med Virol. 2002;66(3):360–9.

Article  PubMed  CAS  Google Scholar 

Gopal MR, Thomson BJ, Fox J, Tedder RS, Honess RW. Detection by PCR of HHV-6 and EBV DNA in blood and oropharynx of healthy adults and HIV-seropositives. Lancet. 1990;335(8705):1598–9.

Article  PubMed  CAS  Google Scholar 

Haque T, Crawford DH. PCR amplification is more sensitive than tissue culture methods for Epstein-Barr virus detection in clinical material. J Gen Virol. 1997;78(Pt 12):3357–60.

Article  PubMed  CAS  Google Scholar 

Stowe RP, Kozlova EV, Yetman DL, Walling DM, Goodwin JS, Glaser R. Chronic herpesvirus reactivation occurs in aging. Exp Gerontol. 2007;42(6):563–70.

Article  PubMed  PubMed Central  CAS  Google Scholar